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thickness; 2.5cm). The skin dose was measured using EBT 
films (read with an Epson Expression Scanner 10000 XL and 
processed with the FilmQAProTM application considering the 
average dose in a ROI) and then compared with the TPS-
calculated average dose in a 3mm thick superficial VOI. The 
plans with virtual bolus were optimized by extending the 
original PTVs outside the body by 5 mm. Two scenarios were 
considered: in the first case a unit density override was 
applied to the PTV, while in the second one the original 
density was considered. The following comparisons were 
performed: measured and TPS-calculated dose with/without 
bolus and virtual bolus; measured dose with/without bolus. 
Results: The mean difference (mean% ± SD%) between 
measured and TPS-calculated dose, in the cases with/without 
bolus, was 16.0% ± 8.0% and 35.7% ± 6.2% respectively. In the 
case of virtual bolus it was 42.4% ± 5.7% (density override; 1) 
and 24.6% ± 7.9% (original density). The mean difference 
(mean% ± SD%) between bolus and no bolus measured dose 
was 15.9% ± 5.4% (p<0.05; t-Student test). 
Conclusions: Although the superficial dose is higher with 
tomohelical treatments than with 3D and fixed-gantry IMRT 
treatments, tissue equivalent bolus should be used if the 
prescribed dose is required to the skin. A better coverage of 
the target may also be obtained using virtual bolus by 
extending the PTV outside the skin, in order to consider 
breathing motion. These preliminary results show that the 
TPS overestimates dose in the build-up region because of the 
inaccuracy of the calculation algorithm in the superficial 
millimeters of skin. Gafchromic EBT3 films are adequate 
instruments for future 'in vivo' skin dose measurements in 
patients with pT4 or infiltrating chest wall carcinoma, as the 
TPS does not give accurate dose values at the surface  
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Purpose/Objective: In order to configure and test a new 
treatment planning system (TPS), clinical physicists are often 
required to obtain dosimetric datasets for small radiation 
fields. During the commissioning process, data entered within 
a TPS should describe the unperturbed dose distribution in 
water as accurately as possible. However, as lateral 
electronic equilibrium breaks down, so does the ability of a 
detector with non-unit density to provide a good surrogate 
for water dose. The research community has investigated this 
issue via the calculation of correction factors to account for 
perturbations introduced by dosimeters within small fields. 
However, the practicability of correction factors within 
clinical commissioning is yet to be clarified. This 
experimental work investigates the magnitude and potential 
impact of correction factors relevant to linac commissioning. 
Materials and Methods: We commissioned two different 
treatment planning systems – Varian's Eclipse and BrainLab's 
iPlan – for a Novalis TrueBeam STX with four beam energies: 
6FFF, 6MV, 10FFF and 10MV. For fields defined by both jaws 
and MLCs (side-lengths ≥ 5mm) we measured datasets using 
three detectors: PTW electron diode 60017 (Ediode), PTW 
microDiamond 60019 (μDiamond) and Standard Imaging 
Scintillator W1. Ashland EBT3 film was used as an 
experimental gold-standard to calculate correction factors 
for the three detectors. 
Results: The scintillator was found to be the best performing 
detector: its on-axis EBT3 correction factors were 
approximately unity for all field sizes and beam energies. 
This result enabled us to use the scintillator as an alternative 
gold standard, reducing experiment time compared to EBT3. 
Good agreement was obtained between the μDiamond and 
Ediode, but both read high relative to the scintillator and 
EBT3. Additionally, for the Ediode a dose-rate dependence 
was observed and its known over-response to low energy 
scatter within large fields was found to be enhanced for 6FFF 
beams relative to 6MV. For the Ediode and μDiamond small to 
large field measurement factor (MF) perturbations are 
plotted in the figure. For a 10mm field the μDiamond 
introduces output factor errors of ~1.5% for 6 MV beams and 
2.5% for 10 MV. 
 
Conclusions: No correction factors are required if the W1 
Scintillator is used to measure small field commissioning 
data. However, this instrument has not yet been fully 
integrated with a scanning water tank, limiting its utility for 
profile and PDD measurement. For centres without access to 
a W1, the μDiamond is recommended over the Ediode. 
Obtaining correction factors using EBT3 is a time-consuming 
and difficult task. At 6 MV and 10 MV the uncorrected 
μDiamond will give results accurate to within 2% for MLC-
defined field sizes above ~10mm and ~15mm respectively, 
such that correction factors may not be required. However, if 
smaller fields are to be utilised or greater accuracy is 
required then correction factors should be applied. 
 
 
 
 
 
